Losartan

Losartan is a prescription medication used to treat high blood pressure and heart failure, and it also shows potential in managing corneal scarring and gout.

Studies have found that losartan can help reduce uric acid levels in the body, which makes it beneficial for people with hyperuricemia or gout. Additionally, topical applications of losartan have been explored for treating corneal fibrosis and stromal scarring following refractive surgery, suggesting its anti-fibrotic properties are effective when applied directly to the eye. Research also indicates that losartan may have anticancer effects by blocking monocyte recruitment in certain types of cancer.

Losartan is connected to renal impairment as a side effect, though this connection is moderate and based on cohort evidence. It's important to note that while there is promising research on various uses of losartan, the breadth of its applications beyond hypertension and heart failure may still be under investigation.

Sources

• Clinical pharmacokinetics of losartan. (PMID:16029066)
• Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma. (PMID:34580111)
• Hyperuricemia and Gout: The Role of Losartan. (PMID:37612850)
• Topical Losartan in the Management of Corneal Scarring Fibrosis: Update on Dosage, Efficacy, and Potential Epithelial Toxicity. (PMID:40238717)
• Topical Losartan in the Treatment of Stromal Scarring After Refractive Surgery. (PMID:40488485)
• Losartan: Comprehensive Profile. (PMID:26051686)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._